Eli Lilly & AnimaBiotech win US Deal of the Year Award
November 15th, 2018
In this video interview with Tim Luker, Senior Director, Emerging Technology & Innovation at Eli Lilly & Co., describes what the collaboration with Anima Biotech and the potential of Anima’s Translation Control Therapeutics technology means to the future of drug discovery at Eli Lilly.